Anbio Biotechnology NNNN

Full chart Compare
Set alert

Price alert · NNNN

All alert types
3.68 USD +0.10 (+2.65%)

At closeNov 4, 2026, 4:00 PM EST

3.70 +0.02 +0.54%

After hours · Nov 4, 4:00 PM ET

3.55 Day range 3.79
3.09 52-week range 44.73
YTD
-87.76%
1 year
-73.66%
Market cap
161.52M
Revenue (ttm)
8.65M
Profit margin
74.06%
EPS (ttm)
0.15
Shares out
43.89M
P/E ratio
24.53
YTD return
-87.76%
1-year return
-73.66%
Volume
22.89K
Avg volume
149.97K
Open
3.55
Previous close
3.59
Day's range
3.55 – 3.79
52-week range
3.09 – 44.73

1Y -18.28 (-83.09%)

2040Dec 25Feb 26May 26Jul 26Sep 263.72

Key statistics

Enterprise value
400.24M
PEG ratio
0.00
Price / sales
47.66
Price / book
13.67
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
73.90%
Free cash flow
-9.61M
Total cash
11.90M
Total debt
0
Return on equity
27.05%
Short % of float
0.20%
50-day average
22.29
200-day average
25.98

Next earnings

Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
NNNN Revenue — annual 8.65M
2022-FY 20222023-FY 20232024-FY 20242025-FY 2025
NNNN Net income — annual 6.40M
2022-FY 20222023-FY 20232024-FY 20242025-FY 2025
NNNN EPS — annual 0.147
2022-FY 20222023-FY 20232024-FY 20242025-FY 2025

About Anbio Biotechnology

Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, and internationally. The company offers lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, SHA dry chemistry, chemiluminescence immunoassay, and real-time polymerase chain reaction solutions; and SARS-CoV-2 and SARS-CoV-2/Flu A/Flu B antigen rapid test kits. It serves over-the-counter, point-of-care testing, and laboratory markets. Anbio Biotechnology was incorporated in 2021 and is based in Frankfurt am Main, Germany.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
Germany

News

Your note

Sign in to keep a note on NNNN — it syncs with the Stock Master app.

Institution ownership

NNNN institution ownership
Holder% heldSharesValueReported
Geode Capital Management, LLC0.06%25,763241.91KMar 30, 2026
BNP Paribas Financial Markets0.02%10,40097.66KMar 30, 2026
Morgan Stanley0.02%7,33868.90KMar 30, 2026
UBS Group AG0.01%6,33959.52KMar 30, 2026
Blue Trust, Inc.0.00%546Mar 30, 2026
Wells Fargo & Company0.00%100939Mar 30, 2026

Fund ownership

NNNN fund ownership
Holder% heldSharesValueReported
Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund0.06%26,736251.05KMay 30, 2026